CDKN2A and cancer: The p16INK4A promoter region is epigenetically regulated by the interplay of repressive modifications, eg H3K27me3, and activating trimethylation of lysine 4 at histone H3 (H3K4me3) in human stem cells, primary fibroblasts and cancer cells [44], [45], [52].